-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Depreciation history and growth rate from Q1 2023 to Q1 2024.
- TC BioPharm (Holdings) plc Depreciation for the quarter ending March 31, 2024 was £115K, a 32.2% decline year-over-year.
- TC BioPharm (Holdings) plc annual Depreciation for 2023 was £597K, a 16.5% decline from 2022.
Depreciation, Quarterly (GBP)
Depreciation, YoY Quarterly Growth (%)